ArticleMolecular therapy. Nucleic acids2014

Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo.

James C Geoghegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.